Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural Anesthesia and Analgesia in Pancreatic Cancer Surgery
NCT03245346Completed
- Sponsor
- Fudan University
- Start
- Dec 2017
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of ropivacaine in pancreatic cancer (PC) (2 arms), sponsored by Fudan University. Primary endpoint: Overall survival at 2 years. Started Dec 2017; status: completed.
02
Drugs
ropivacaine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT03245346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03245346.